Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Gyan K. Kayastha, Padma Gurung, Paras K. Acharya, Buddhi P. Paudyal, Bruce Hayes, Mark Zimmerman, Arjun Karki, Aaron S. Mansfield

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences